BASF keeps Evonik talks open. BASF stock sits 6.28 percent below its 52-week high.

Published on 10/13/2026 at 10:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

BASF stock costs EUR 51.59 on October 13, 2026, 0.62 percent above EUR 51.27. Third-quarter results are due October 28, 2026.

BASF kept exploratory Evonik acquisition talks open on October 13, 2026, while the stock stood 6.28 percent below its 52-week high.
Second-quarter 2026 revenue rose 16.00 percent to EUR 17.20 billion, while adjusted EBITDA before special items reached EUR 2.40 billion.
BASF repurchased 215,302 shares from October 5 through October 9, bringing cumulative buybacks since August 3 to 6,046,289 shares.
The third-quarter 2026 results are scheduled for October 28, 2026, followed by BASF's Capital Markets Day on November 23 and November 24.

Aquarellmalerei einer Flussstadt mit Chemieanlagen-Silhouette am Rhein bei Sonnenuntergang — BASF SE (ISIN DE000BASF111) hat Hauptsitz in Ludwigshafen am Rhein nahe großen Chemieanlagen, Illustration mit AI erstellt.

BASF (ISIN DE000BASF111) was trading at EUR 51.59 at Lang & Schwarz on October 13, 2026, at 10:08 a.m. CEST. On October 13, European Coatings reported that BASF kept exploratory talks over a possible Evonik acquisition open, leaving the stock 6.28 percent below its 52-week high of EUR 55.05.

Three events changed the picture

On July 15, 2026, EQS News reported that BASF's second-quarter 2026 revenue rose 16.00 percent to EUR 17.20 billion from EUR 14.80 billion.

On September 25, 2026, the Evonik discussions carried an initial offer of EUR 22.15 per Evonik share, according to European Coatings. On October 12, 2026, BASF reported through TradingView that it had repurchased 215,302 shares from October 5 through October 9.

What does the buyback add?

The repurchase program had reached 6,046,289 shares between August 3 and October 9, according to TradingView. Against a market capitalization of EUR 44.6 billion on October 13, 2026, the buyback is a capital-return signal, while the unresolved Evonik discussions add a separate strategic variable.

The second-quarter figures also contained a quality caveat. BASF's adjusted EBITDA before special items reached EUR 2.40 billion, up from EUR 1.60 billion in the second quarter of 2025, while the reported EUR 4.10 billion after-tax result included a EUR 3.90 billion pretax gain from the Coatings transaction, according to EQS News. The distinction matters because the transaction gain does not describe recurring chemical operations.

Parmantier & Cie. gave BASF a Buy recommendation and a EUR 59.00 12-month price target on October 6, 2026, according to FinanzNachrichten.de. That target lies 14.36 percent above the Lang & Schwarz price, providing a quantified market view alongside the operational and strategic questions.

Key dates for BASF stock

BASF's investor-relations calendar lists the third-quarter 2026 financial report for October 28, 2026, and the Capital Markets Day for November 23 and November 24, 2026. The dates are published on BASF's investor-relations page.

Stock stays below its yearly high

At EUR 51.59, BASF was 0.62 percent above the Xetra close of October 12, 2026, at EUR 51.27. The 52-week range was EUR 41.48 to EUR 55.05 on October 13, 2026, and the stock's position leaves the next results and the Evonik discussions as the clearest dated reference points. The further course of trading is shown by the continuously updated real-time quote of BASF stock.